Contact Us
admin@ausbiotech.org
Home

Newsroom.

Publications and reports

AusBiotech 2025 Annual Report

Previous Annual Reports
2024 2023 2022
2021 2020 2019
2018 2017 2016
2015 2014 2013

AusBiotech’s journal, Australasian Biotechnology

Australasian Biotechnology is AusBiotech’s official journal, reporting on research and business news within the biotechnology arena.

With its informed and authoritative editorial, Australasian Biotechnology is a highly effective marketing and advertising vehicle for universities, research institutes and centres, and life science companies wanting to reach out to decision-makers in government and throughout all branches of the life sciences sector.

The journal is published twice a year by Executive Media.

Enquiries

Please submit your editorial enquiries for the journal to Emma Boscheinen, Director Communications.
To find out more about advertising, please contact Executive Media at media@executivemedia.com.au or 03 9274 4200.

Publications

National Biotech and Medtech Development and Commercialisation Summit 2024 Discussion Paper

NEW: National Biotech and Medtech Development and Commercialisation Summit 2024 | Discussion paper

 Economic impact of the R&DTI for the biotech industry A practical guide to ESG for Australian life sciences companies
US Investment in Australian Life Sciences Snapshot 2023 National Cell and Gene Manufacturing Blueprint Australian Life Sciences Incubator and Accelerator Programmes
Australian Biotechnology Sector Snapshot 2022 Biotechnology Blueprint: A decadal strategy for the Australian biotechnology industry Accelerating Health and Medical Research Commercialisation in Australia - Main report
Green cover of Investments Database report, photo of cells, name of report, and seven logos of consortium members Pink cover of Regenerative Medicine in Australia - Strategic Roadmap for the Regenerative Medicines Sector report, photo of cells, name of report, and seven logos of consortium members
Research Commercialisation in Australia - Companion report Australia’s Regenerative Medicine Investments Database Strategic Roadmap for the Regenerative Medicine Sector
Burnt orange cover of Clinical Trials Database report, photo of DNA strand, name of report, and seven logos of consortium members
Case Studies: Cell, Gene, Gene Modified Cell and Tissue Engineered Products Australia’s Regenerative Medicine Global Pipeline Tracker Australia’s Regenerative Medicine Clinical Trials Database

Green cover of Manufacturing report, photo of cells, name of report, and seven logos of consortium members Pink and purple cover with DNA strand, name of the report 'The regenerative medicine value chain' and seven consortium members' logos.
Australia’s Regenerative Medicine Catalyst Body Funding & Model Structure Australia’s Regenerative Medicine Manufacturing Capacity & Capability The Regenerative Medicine Value Chain, The pathway from discovery to patient delivery

Cover of RDTI report - four images from biotech pipeline, and name of report.
R&D Tax Incentive: Additionality and spillovers for the life sciences industry Official reference guide to agricultural biotechnology and GM crops, fourth edition. Antimicrobial resistance (AMR) Industry Position Paper
Cover of latest Industry Position Survey report - top half has a green and blue cell picture, bottom half has the year. Cover of Sector Snapshot 2019 report - light blue with colourful nodules at the right hand edge, plus name of report Cover of Cellular Therapies and Regenerative Medicine in Australia - grey cover with text across, and a green map of Australia with clusters showing company presence
Biotechnology Industry Position
Survey of CEOs		 Australia's Life Sciences Sector Snapshot 2019 Cellular Therapies and
Regenerative Medicine in
Australia 2019
Cover of Regenerative Medicine: Opportunities for Australia. DNA strand on top half of report, with report name and logos on bottom half Cover of Australian Innovation and Manufacturing (AIM) Incentive report - report title and year at the top with a person manufacturing biological matter and logos.
Regenerative medicine: Opportunities
for Australia (2018)		 Australian Innovation and
Manufacturing (AIM) Incentive:
Who cares about Australia’s
future? WE DO, 2015

Best practice publications for biotech companies and investors

AusBiotech is committed to fostering relationships between life science companies and investors, helping companies overcome the notorious “valley of death” and assisting investors in connecting with innovative, Australian companies that offer high-value return-on-investment.

AusBiotech has prepared a number of resources to assist Australian life science companies in working with investors and navigating the investment market.

Cover of Code of Best Practice 2013 report Cover of Guide for Life Science Company Directors_2013 Cover of Corporate Governance in the ASX-Listed Life Sciences Sector report
Code of Best Practice for Reporting
by Life Science Companies		 Guide for Life Science
Company Directors		 Corporate Governance in the
ASX-Listed Life Sciences Sector
Grey and purple cover of Guide to Life Sciences Investing report Grey and purple cover of Roadmap to a successful IPO for life sciences companies report Red and gold cover of China Guide report
Guide to Life Sciences Investing Roadmap to a successful IPO for
life sciences companies		 The China Guide

Reports from other organisations

The McKell Institute presents a series of recommendations that will help build a stronger biotechnology industry and advocates for more Government funding to be provided to AusBiotech.

This report captures multi-stakeholder perspectives on the opportunities afforded by biologic and biosimilar medicines in Australia and the key steps required to advance the evolving framework for the introduction and use of these medicines, in alignment with the National Medicines Policy. AusBiotech was listed on the Organising Committee.

Australasian Biotechnology - journal